Drug
Colesevelam
Colesevelam: highest development phase Phase 3, developed by Daiichi Sankyo. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Daiichi Sankyo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Colesevelam hydrochloride NCT00147719 | Phase 3 | Type 2 Diabetes |
| Colesevelam NCT00147745 | Phase 2 | Type 2 Diabetes |
Latest
No recent events.
Follow Colesevelam on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.